Dr. Nasser H. Hanna is a medical oncologist focused on thoracic oncology in Indianapolis, Indiana. He is the Associate Division Director of the Department of Oncology, as well as the Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research and a Professor of Medicine in the Division of Hematology/Oncology at the Indiana
As a pulmonologist and critical care specialist, Dr. Francis D. Sheski is an invaluable member of Indiana University’s cancer treatment program and the Indiana University School of Medicine in Indianapolis, Indiana. His clinical interests include interventional pulmonology for lung cancer and pleural diseases, and he specializes in bronchoscopy and thoracoscopy. Education Dr. Sheski has an
Dr. Darren Bryan is a thoracic surgeon who has dedicated himself to caring for patients with lung cancer, pleural mesothelioma, and other thoracic conditions. He is a member of the University of Chicago Comprehensive Cancer Center’s mesothelioma treatment team, using his skills in both traditional and minimally invasive/robotic surgical techniques to provide the best outcomes for his
Dr. Mark Ferguson is a thoracic and cardiac surgeon at the University of Chicago Medicine. His surgical specialty is the management of lung, esophageal, and thymus diseases. He is experienced in all techniques of lung and esophageal resection, as well as the management of malignant pleural effusions. Education and Career Board-certified in thoracic surgery, Dr.
Dr. Jessica S. Donington is a thoracic surgeon and clinical researcher whose particular interests and skills are the treatment of lung cancer, esophageal cancer, and mediastinal conditions. As Chief of the University of Chicago’s Department of Surgery’s Thoracic Surgery section, she specializes in the multidisciplinary care of both benign and malignant chest diseases, including lung
Dr. Ankit Bharat is a board-certified thoracic surgeon and general surgeon whose clinical focus is on the treatment of malignant and benign chest diseases, including lung cancer and malignant pleural mesothelioma. He is the Chief of Thoracic Surgery at Northwestern Medicine, as well as the Harold L. and Margaret N. Method Professor of Surgery and
A follow-up survey conducted by the National Comprehensive Cancer Network (NCCN) has revealed that though shortages of chemotherapy drugs are continuing, they are having little to no impact on mesothelioma patients and others diagnosed with other cancers. Experts attribute this to the adoption of strict protocols and strategies regarding the use of available resources. Chemotherapy Drug Shortages
The International Association for the Study of Lung Cancer held its 2023 World Conference on Lung Cancer last week, and much of the information presented focused on discoveries in malignant mesothelioma. One clinical trial’s results were presented focused on the importance of dendritic cells and how they can be leveraged to stimulate immune responses.
Dr. Mohamed E. Abazeed is a radiation oncologist and scientist dedicated to improving outcomes for patients with lung cancer and other tumors, including pleural mesothelioma. He is the Co-Leader of the Lung Cancer Program at the Robert H. Lurie Comprehensive Cancer Center and an active member of the Translational Research in Solid Tumors (TRIST) program
Dr. Momen Wahidi is an internationally respected expert in interventional pulmonology and bronchoscopy with a special interest in patients with lung cancer and pleural diseases, including pleural mesothelioma and interstitial lung disease. He is the Medical Director for the Canning Thoracic Institute as well as a Professor of Medicine at Northwestern’s Feinberg School of Medicine.